论文部分内容阅读
笔者在临床输液时发现灯盏花素注射液与硫普罗宁注射液在使用过程中出现黄色絮状物及沉淀,现报道如下。1病历摘要男,82岁。因发现肺癌10 a余,为进一步复查收入我科,入院后给予扩冠及对症治疗,其中出现静脉滴注5%葡萄糖注射液100 ml加注射用灯盏花素50 mg(衡阳恒升制药有限公司,产品批号:20090630),静脉滴注完毕后,换0.9%氯化钠注射液100 ml加注射用硫普罗宁0.2 g(悦康药业集团有限公司
The author found in clinical transfusion breviscapine injection and tiopronin injection during the use of yellow floc and precipitation, are reported below. 1 medical record summary male, 82 years old. Because of the discovery of lung cancer more than 10 a, to further review the income of our department, after admission to give the crown and symptomatic treatment, which appeared intravenous infusion of 5% dextrose injection plus 100 mg of Breviscapine 50 mg (Hengyang Hengsheng Pharmaceutical Co., Ltd. , Product batch number: 20090630), after the intravenous infusion, for 0.9% sodium chloride injection 100 ml plus injection tiopronin 0.2 g (Yue Kang Pharmaceutical Group Co., Ltd.